A Review Article on Recent Advancements in the cardiovascular Drug Carriers and Animal Models Used in Treatment of Hypertension

  • Unique Paper ID: 180886
  • Volume: 12
  • Issue: 1
  • PageNo: 3622-3626
  • Abstract:
  • cardiovascular diseases the infection that influences the cardiovascular system, regardless of all advances in pharmacological and clinical treatment, heart failure is a main reason for morbid ness and mortality around the world. many new therapeutic advance strategies, including cell transplantation, gene delivery or therapy, and cytokines or other small molecules, have been research to treat heart failure. The principal point of this review article is to focus on nano carriers’ advancement and resolving the issues related with old and present-day therapeutics such as nonspecific effects and poor stability. Experimental animal models of hypertension have turned into a significant instrument for giving data on etiology, pathophysiology, and complications of the disease and on the adequacy and mechanism of action of different medications and compounds utilized in treatment. An animal model has been developed to study hypertension for several reasons because of multiple factors. Compared to human models, an animal model is easily manageable. Blood vessels and cardiac tissue samples can be taken for detailed experimental and biomolecular examination. In conclusion, animal models for hypertension and atherosclerosis are invaluable in improving our understanding of cardiovascular disease and developing new pharmacological therapies

Copyright & License

Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

BibTeX

@article{180886,
        author = {Komal K Raval and Dr. Shyam Sunder Pancholi},
        title = {A Review Article on Recent Advancements in the cardiovascular Drug Carriers and Animal Models Used in Treatment of Hypertension},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {1},
        pages = {3622-3626},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=180886},
        abstract = {cardiovascular diseases the infection that influences the cardiovascular system, regardless of all advances in pharmacological and clinical treatment, heart failure is a main reason for morbid ness and mortality around the world. many new therapeutic advance strategies, including cell transplantation, gene delivery or therapy, and cytokines or other small molecules, have been research to treat heart failure. The principal point of this review article is to focus on nano carriers’ advancement and resolving the issues related with old and present-day therapeutics such as nonspecific effects and poor stability.  Experimental animal models of hypertension have turned into a significant instrument for giving data on etiology, pathophysiology, and complications of the disease and on the adequacy and mechanism of action of different medications and compounds utilized in treatment. An animal model has been developed to study hypertension for several reasons because of multiple factors. Compared to human models, an animal model is easily manageable. Blood vessels and cardiac tissue samples can be taken for detailed experimental and biomolecular examination. In conclusion, animal models for hypertension and atherosclerosis are invaluable in improving our understanding of cardiovascular disease and developing new pharmacological therapies},
        keywords = {cardiovascular disease, gene therapy, nanotechnological approaches, Nanoparticle, animal model, hypertension},
        month = {June},
        }

Related Articles